Xenon Pharmaceuticals Inc.
Clinical trials sponsored by Xenon Pharmaceuticals Inc., explained in plain language.
-
New hope for Long-Term bipolar depression treatment
Disease control ENROLLING_BY_INVITATIONThis study aims to understand the long-term safety and effectiveness of the drug azetukalner for adults with bipolar depression. It is open to 400 participants who successfully completed a previous Phase 3 trial of the same drug. The main goal is to monitor side effects and see i…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 02, 2026 09:11 UTC
-
New depression drug enters final Long-Term safety testing
Disease control ENROLLING_BY_INVITATIONThis study follows adults with major depressive disorder who previously participated in related research to see how safe and effective the experimental drug azetukalner is over a longer period. About 460 participants will continue taking the medication while researchers monitor s…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Epilepsy patients get chance for 3-Year drug trial
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effectiveness of the drug XEN1101 for controlling seizures. It is open to about 880 people with focal epilepsy or tonic-clonic seizures who have already completed a previous related study. Participants will take the drug dai…
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC